Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1964 Dec 5;91(23):1200–1202.

The Use of Lysergic Acid Diethylamide (LSD) in Psychotherapy

E F W Baker
PMCID: PMC1928491  PMID: 14226093

Abstract

One hundred of 150 patients with non-psychotic functional psychiatric disorders were benefited by the use of LSD psychotherapy. The dosage of LSD employed was 25 to 2000 micrograms intramuscularly per session for from one to 10 sessions. On this regimen four patients became psychotic and required electroconvulsive therapy. None were permanently harmed.

Indications for and contraindications to this form of treatment and a procedure involving a doctor and a nurse as co-therapists are discussed. In particular, LSD is considered to permit “perceptualization of the transference”.

LSD possibly extends the scope and value of the psychotherapeutic approach in such cases.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ROTHLIN E. Pharmacology of lysergic acid diethylamide and some of its related compounds. J Pharm Pharmacol. 1957 Sep;9(9):569–587. doi: 10.1111/j.2042-7158.1957.tb12312.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES